Diabetic Retinopathy: A New Treatment Paradigm Using EyePromise^® DVS and Diopsys^® ERG

A Webinar with Nate Lightizer, OD, FAAO Diabetes is a common disease that can have a potent effect on the retina. Abnormalities caused by oxidative stress and even inflammation can begin to show as early as 1 month after onset. Eye care providers can objectively evaluate retinal function using Diopsys^® ffERG/Flicker vision tests, potentially catching deficiencies of the retina even before vascular abnormalities develop.^1-4 Once identified, dysfunction may then be improved by EyePromise^® DVS nutritional supplements.^5-6 Please join Dr. Lighthizer as he discusses the need for objective, functional testing of the retina and the use of supplements in diabetic patients to help identify, track, and respond to vision problems sooner. This webinar is co-sponsored by

1. Wroblewski, John J., et al. Reproducibility of Fixed-Luminance and Multi-Luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-Based Testing Paradigm. Journal of Diabetes Science and Technology, Oct. 2019, doi:10.1177/1932296819882719. 2. Holm K, et al. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema. Doc Ophthalmol. 2015;131:43-51. 3. Pescosolido N, et al. Role of Electrophysiology in the Early Diagnosis and Follow-Up of Diabetic Retinopathy. J Diabetes Res. 2015;doi.org/10.1155/2015/319692. 4. Tzekov R, et al. The Electroretinogram in Diabetic Retinopathy Surv Ophthalmol. 1999;doi:10.1016/s0039-6257(99)00063-6. 5. Chous AP, et al. The Diabetes Visual Function Supplement Study (DiVFuSS). Br J Ophthalmol. 2016;doi:10.1136/bjophthalmol-2014-306534. 6. Kowluru RA, et al. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab. 2014;doi:10.1186/1743-7075-11-8.